FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1977091674> ?p ?o ?g. }

• W1977091674 endingPage "256" @default.
• W1977091674 startingPage "251" @default.
• W1977091674 abstract "Background and Purpose: There is no treatment proven to be of definitive benefit for ischemic stroke. Arginine esterase, a natural product from a snake venom, has been shown to reduce the serum fibrinogen level in human beings and may be useful in the treatment of ischemic stroke. In the present study, we compared the therapeutic effect of arginine esterase with that of heparin. Subjects and Methods: We studied 50 consecutive patients with acute ischemic stroke who were admitted to the Asan Medical Center. We randomly administered either arginine esterase 0.005 unit/kg × 2 times/day or heparin (activated partial thromboplastin time 2–3 times of baseline value) intravenously for 7 days. Antiplatelets were administered afterwards in both groups. Blood fibrinogen, fibrinogen degradation product (FDP) and D-dimer levels were measured at 0, 6, 12, 18 h and 1, 2, 3, 7 and 30 days after the onset of stroke. NIH stroke scale was measured daily by 2 neurologists while Barthel index and Rankin scale were assessed at 7 days and 1 month after the onset of stroke by a research nurse. All these investigators were blinded to the therapeutic regimen each patient received. Results: There were no significant differences in the mean age, gender proportion, stroke subtypes and baseline neurological severity between the two groups. One patient in the arginine esterase group died in an acute stage due to massive herniation and 1 in the heparin group underwent surgery for herniation. One (arginine esterase group) died of massive gastrointestinal bleeding due to previously unrecognized stomach cancer. Otherwise, no significant clinical and laboratory side effects were observed in both groups. In the arginine-esterase treated group, D-dimer and FDP levels were significantly (p < 0.05) elevated, and fibrinogen level significantly (p < 0.05) decreased at 2–7 days after the onset of stroke compared to the heparin-treated group. However, there was no significant difference in the neurological improvement reflected by NIH stroke scale, Barthel index and Rankin scale. Conclusion: Arginine esterase seems to be safe and has significant fibrinolytic effects when administered in the patients with acute ischemic stroke. However, in this preliminary study, it was not superior to heparin in terms of the improvement of neurological deficits. Further studies with larger doses and a larger number of subjects are required." @default.
• W1977091674 created "2016-06-24" @default.
• W1977091674 creator A5009033183 @default.
• W1977091674 creator A5034094507 @default.
• W1977091674 creator A5052716781 @default.
• W1977091674 creator A5057751049 @default.
• W1977091674 creator A5065368519 @default.
• W1977091674 creator A5067656534 @default.
• W1977091674 date "2001-01-01" @default.
• W1977091674 modified "2023-09-27" @default.
• W1977091674 title "Treatment of Acute Cerebral Infarction with Arginine Esterase: A Controlled Study with Heparin" @default.
• W1977091674 cites W1498265361 @default.
• W1977091674 cites W178588763 @default.
• W1977091674 cites W2012348864 @default.
• W1977091674 cites W2022553406 @default.
• W1977091674 cites W2023696392 @default.
• W1977091674 cites W2028793756 @default.
• W1977091674 cites W2029365702 @default.
• W1977091674 cites W2075946336 @default.
• W1977091674 cites W2083510699 @default.
• W1977091674 cites W2107043311 @default.
• W1977091674 cites W2141347187 @default.
• W1977091674 cites W2164533338 @default.
• W1977091674 cites W2171066092 @default.
• W1977091674 cites W2292308933 @default.
• W1977091674 cites W2313868127 @default.
• W1977091674 cites W2400345455 @default.
• W1977091674 cites W2413036166 @default.
• W1977091674 cites W2550100491 @default.
• W1977091674 cites W2588540426 @default.
• W1977091674 doi "https://doi.org/10.1159/000047647" @default.
• W1977091674 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11306776" @default.
• W1977091674 hasPublicationYear "2001" @default.
• W1977091674 type Work @default.
• W1977091674 sameAs 1977091674 @default.
• W1977091674 citedByCount "7" @default.
• W1977091674 countsByYear W19770916742013 @default.
• W1977091674 countsByYear W19770916742014 @default.
• W1977091674 countsByYear W19770916742015 @default.
• W1977091674 countsByYear W19770916742021 @default.
• W1977091674 crossrefType "journal-article" @default.
• W1977091674 hasAuthorship W1977091674A5009033183 @default.
• W1977091674 hasAuthorship W1977091674A5034094507 @default.
• W1977091674 hasAuthorship W1977091674A5052716781 @default.
• W1977091674 hasAuthorship W1977091674A5057751049 @default.
• W1977091674 hasAuthorship W1977091674A5065368519 @default.
• W1977091674 hasAuthorship W1977091674A5067656534 @default.
• W1977091674 hasConcept C126322002 @default.
• W1977091674 hasConcept C127413603 @default.
• W1977091674 hasConcept C141071460 @default.
• W1977091674 hasConcept C2777557582 @default.
• W1977091674 hasConcept C2778261982 @default.
• W1977091674 hasConcept C2778382381 @default.
• W1977091674 hasConcept C2779036427 @default.
• W1977091674 hasConcept C2779450755 @default.
• W1977091674 hasConcept C2780645631 @default.
• W1977091674 hasConcept C2780931571 @default.
• W1977091674 hasConcept C3020199598 @default.
• W1977091674 hasConcept C42219234 @default.
• W1977091674 hasConcept C541997718 @default.
• W1977091674 hasConcept C71924100 @default.
• W1977091674 hasConcept C78519656 @default.
• W1977091674 hasConcept C90924648 @default.
• W1977091674 hasConceptScore W1977091674C126322002 @default.
• W1977091674 hasConceptScore W1977091674C127413603 @default.
• W1977091674 hasConceptScore W1977091674C141071460 @default.
• W1977091674 hasConceptScore W1977091674C2777557582 @default.
• W1977091674 hasConceptScore W1977091674C2778261982 @default.
• W1977091674 hasConceptScore W1977091674C2778382381 @default.
• W1977091674 hasConceptScore W1977091674C2779036427 @default.
• W1977091674 hasConceptScore W1977091674C2779450755 @default.
• W1977091674 hasConceptScore W1977091674C2780645631 @default.
• W1977091674 hasConceptScore W1977091674C2780931571 @default.
• W1977091674 hasConceptScore W1977091674C3020199598 @default.
• W1977091674 hasConceptScore W1977091674C42219234 @default.
• W1977091674 hasConceptScore W1977091674C541997718 @default.
• W1977091674 hasConceptScore W1977091674C71924100 @default.
• W1977091674 hasConceptScore W1977091674C78519656 @default.
• W1977091674 hasConceptScore W1977091674C90924648 @default.
• W1977091674 hasIssue "3" @default.
• W1977091674 hasLocation W19770916741 @default.
• W1977091674 hasLocation W19770916742 @default.
• W1977091674 hasOpenAccess W1977091674 @default.
• W1977091674 hasPrimaryLocation W19770916741 @default.
• W1977091674 hasRelatedWork W1963820157 @default.
• W1977091674 hasRelatedWork W1990662410 @default.
• W1977091674 hasRelatedWork W2017892344 @default.
• W1977091674 hasRelatedWork W2317139092 @default.
• W1977091674 hasRelatedWork W2355380694 @default.
• W1977091674 hasRelatedWork W2377919110 @default.
• W1977091674 hasRelatedWork W2380904828 @default.
• W1977091674 hasRelatedWork W2412661101 @default.
• W1977091674 hasRelatedWork W2415392075 @default.
• W1977091674 hasRelatedWork W2898295094 @default.
• W1977091674 hasVolume "11" @default.
• W1977091674 isParatext "false" @default.
• W1977091674 isRetracted "false" @default.
• W1977091674 magId "1977091674" @default.

• next